Guest: Pavani Chalasani MD, MPH <br>


  <p>Dr. Pavani Chalasani, Associate Professor of Medicine and Program Director of the Hematology/Oncology Fellowship at the University of Arizona Cancer Center, examines current clinical trials investigating the role of CDK 4/6 inhibitors in early stage HER positive and HER2 negative breast cancer treatment.</p>

Guest: Pavani Chalasani MD, MPH Dr. Pavani Chalasani, Associate Professor of Medicine and Program Director of the Hematology/Oncology Fellowship at the University of Arizona Cancer Center, examines current clinical trials investigating the role of CDK 4/6 inhibitors in early stage HER positive and HER2 negative breast cancer treatment.

Targeting CDK4/6I Pathways for Early-Stage HR+/HER2- Breast Cancer Treatment

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Medicine

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology®&nbsp;educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Share Targeting CDK4/6I Pathways for Early-Stage HR+/HER2- Breast Cancer Treatment

Sign up to save your podcasts

Targeting CDK4/6I Pathways for Early-Stage HR+/HER2- Breast Cancer Treatment

Targeting CDK4/6I Pathways for Early-Stage HR+/HER2- Breast Cancer Treatment